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The small heat-shock proteins HSPB2 and HSPB3 form well-defined
heterooligomers in a unique 3 to 1 subunit ratio
Abstract
Various mammalian small heat-shock proteins (sHSPs) can interact with one another to form large
polydisperse assemblies. In muscle cells, HSPB2/MKBP (myotonic dystrophy protein kinase-binding
protein) and HSPB3 have been shown to form an independent complex. To date, the biochemical
properties of this complex have not been thoroughly characterized. In this study, we show that
recombinant HSPB2 and HSPB3 can be successfully purified from E.coli cells co-expressing both
proteins. Nanoelectrospray ionization mass spectrometry and sedimentation velocity analytical
ultracentrifugation analysis showed that HSPB2/B3 forms a series of well defined hetero-oligomers,
consisting of 4, 8, 12, 16, 20 and 24 subunits, each maintaining a strict 3:1 HSPB2:HSPB3 subunit ratio.
These complexes are thermally stable up to 40 °C, as determined by far-UV circular dichroism
spectroscopy. Surprisingly, HSPB2/B3 exerted a poor chaperone-like and thermoprotective activity, which
is likely related to the low surface hydrophobicity, as revealed by its interaction with the hydrophobic
probe 1-anilino-8-naphthalenesulfonic acid. Co-immunoprecipitation experiments demonstrated that the
HSPB2/B3 oligomer cannot interact with HSP20, HSP27 or αB-crystallin, whereas the homomeric form of
HSPB2, thus not in complex with HSPB3, could efficiently associate with HSP20. Taken altogether, this
study brings evidence that despite the high sequence homology within the sHSP family, the biochemical
properties of the HSPB2/B3 complex are distinctly different from other sHSPs, indicating that the HSPB2/
B3 assembly likely possesses other cellular functions than its family members.
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Various mammalian small heat shock proteins (sHSPs) can interact with one another to
form large polydisperse assemblies. In muscle cells, HSPB2/MKBP (myotonic dystrophy protein
kinase-binding protein) and HSPB3 have been shown to form an independent complex. To date,
the biochemical properties of this complex have not been thoroughly characterized. In this
study, we show that recombinant HSPB2 and HSPB3 can be successfully purified from E.coli
cells co-expressing both proteins. Nanoelectrospray ionization mass spectrometry and
sedimentation velocity analytical ultracentrifugation analysis showed that HSPB2/B3 forms a
series of well defined hetero-oligomers, consisting of 4, 8, 12, 16, 20 and 24 subunits, each
maintains a strict 3:1 HSPB2:HSPB3 subunit ratio. Analyzing the thermal stability of the
HSPB2/B3 assembly by far-UV circular dichroism spectroscopy revealed subtle structural
changes, occurring slightly above 40 °C, and an unfolding curve with an inflection point at
approximately 56 °C. Furthermore, HSPB2/B3 exerted poor chaperone-like and
thermoprotective activity, which is likely related to the low surface hydrophobicity, as revealed
by its interaction with the hydrophobic probe 1-anilino-8-naphthalenesulfonic acid. Finally, coimmunoprecipitation experiments demonstrated that the HSPB2/B3 oligomer does not interact
with HSP20, HSP27 or αB-crystallin. However, HSPB2 that is not in complex with HSPB3 was
found to efficiently associate with HSP20. Taken altogether, this study brings evidence that
despite the high sequence homology of the subunits to other sHSPs, biochemical properties of
the HSPB2/B3 complex are distinct different from other sHSP assemblies. Our results clearly
demonstrate that HSPB2/B3 forms well-defined oligomeric complexes with poor chaperone-like
activity.
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activity of DMPK and protects it from heatinduced inactivation (25). Association of HSPB2
with the outer membrane of mitochondria
suggests a role in mitochondrial function
(26;27). This might be related to the observed
role of HSPB2 in the protection of the energy
reserve; mice lacking HSPB2 have a higher rate
of ATP loss during ischemic stress, and after
ischemia the recovery of the energy level was
slower (28). HSPB2 has been also implicated in
the pathogenesis of diseases. In myotonic
dystrophy diseased muscles, with reduced
DMPK levels, an increased expression of
HSPB2 is observed (25). Furthermore, HSPB2

INTRODUCTION
Small heat shock proteins (sHSPs) are
molecular chaperones characterized by the
presence of a conserved sequence of about 80100 residues, referred to as the α-crystallin
domain (for recent reviews see (1-3). This
domain forms the C-terminal part of the protein,
and is folded into a β-sandwich structure (4-6).
The N-terminal part is more variable in both
length and sequence, and largely determines the
association properties of the homo- or
heteromeric oligomers of sHSPs (7-9). The αcrystallin domain generally has a short and
flexible C-terminal extension which modulates
the chaperone-like activity, possessed by most
sHSPs (10-12). sHSPs can form macromolecular
associations up to 800 kDa, which readily
dissociate and exchange subunits (13;14). In
vitro, sHSPs typically display chaperone-like
activities, measured by their ability to protect
model substrates from thermally or chemically
induced aggregation (15;16). In vivo, different
sHSPs are implicated in an array of cellular
processes, varying from muscle contraction, cell
migration and cell survival to redox state and
apoptosis (see reviews see (17-19)).
In human, ten members of the sHSP
family have been recognized, formally
designated as HSPB1-HSPB10 (20;21). While
several sHSPs have extensively been studied,
only limited information is available for HSPB2
(MKBP) and HSPB3 (22). HSPB2 and HSPB3
are mainly expressed in heart and skeletal
muscle (23;24). In muscle extract HSPB2 and
HSPB3 has been identified as a hetero-oligomer
with an apparent molecular mass of 150 kDa.
This sHSP complex has a more defined size than

can associate with the Aβ-containing plaques in
Alzheimer’s disease brains possibly preventing
the pathogenic action of Aβ (29;30).
Less is known about HSPB3. Based on
sequence prediction, HSPB3 was found to be the
smallest member of the family with a 17 kDa
monomeric size (31). A remarkable feature of
HSPB3 is the lack of the C-terminal extension
(31). In heart extracts, it exclusively interacts
with HSPB2 (23), and upon proteasomal
inhibition, ectopically overexpressed HSPB3 can
translocate to the cytoskeleton in cultured rat
cardiac H9C2 cells (32). Like HSPB2, the
expression levels of HSPB3 are not upregulated
upon heat shock (23).
Our goals in this study were two-fold:
(1) to establish the stoichiometry of the
oligomeric assembly of HSPB2/B3 and (2) to
characterize the biochemical properties of the
complex. We show that HSPB2 and HSPB3
form a series of complexes that are actually
assemblies of tetrameric HSPB2/B3 complexes
with a subunit ratio of 3:1. These oligomers were
found to have poor chaperone and
thermoprotective activity and are unable to
interact with other sHSPs, such as HSP20,

those formed by HSP27, αB-crystallin or
HSP20, which can vary between 40 and 500 kDa
(23). HSPB2 was initially discovered as a
specific binding partner for myotonic dystrophy
protein kinase (DMPK), hence its alternative
name MKBP (DMPK-binding protein) (25).
This interaction results in an enhanced kinase

HSP27 and αB-crystallin.
EXPERIMENTAL PROCEDURES
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Cloning, expression and purification
The cDNAs encoding for rat HSPB2 and
rat HSPB3 were cloned into the pET3a
expression vector by using the NdeI-BamHI
sites and BglII-EcoRI sites, respectively. Protein
expression was induced in the BL21 Rosetta
strain, transformed with pET3a-HSPB2/B3, by

CD-spectra were recorded on a J-810
spectropolarimeter (Jasco) in a 1 mm cuvette
using 250 µg/mL of HSPB2/B3 dialyzed against
10 mM potassium phosphate buffer pH 7.8.
Spectra of HSPB2/B3 and buffer alone were
recorded between 195 and 250 nm with a
scanning speed of 20 nm/min with a response
time of 1 second and a bandwidth set to 1 nm.
To determine the heat stability, the temperature
of the cuvette was increased from 20 °C up to 80
°C with 1 °C /min. After each increment of 2 °C
15 spectra were recorded and averaged. The
spectra of HSPB2/B3 were corrected for the
spectra of the buffer at the corresponding
temperatures.
Mass spectrometry
HSPB2/B3 was buffer exchanged from
the initial buffer into200 mM ammonium
acetate, pH 6.8, using a Superdex 200 column on
an AKTA prime FPLC and subsequently
separated into two fractions, A and B, on a
Superose 6 column.
From these fractions
nanoelectrospray mass spectra were acquired
using a Qstar XL mass spectrometer (MDS
Sciex), under conditions optimized for the
transmission of non-covalent protein complex
interactions, using a previously described
protocol (34). Typical instrument parameters in
positive ion mode, were: ion spray voltage 1.2
kV, declustering potential 100 - 150 V, focusing
potential 100 V, declustering potential 2 15V,
quadrupole voltage (Q0) 50 V, collision gas
(CAD) 6, ion release delay 6 and ion release
width 5.
Experiments were acquired at
instrument base pressure of 6.5 mbar.
Analytical ultracentrifugation
Samples were placed in assembled cells
with sapphire windows and 12-mm path length
centerpieces, which were made of charcoal-filled
epon, and were centrifuged at 42,000 rpm in an
eight-holed An50-Ti rotor. The data were
collected using the absorption detection system
of the XL-I analytical ultracentrifuge (Beckman
Coulter) at 276 nm. The cells were aligned

addition
of
350
µM
isopropyl-β-Dthiogalactopyranoside and subsequent incubation
for three hours at 37 °C. Cells were lysed by
sonication in TEG buffer (25 mM Tris, pH 8.0, 2
mM ethylenediaminetetraacetic acid (EDTA), 50
mM glucose) and then centrifuged at 16,000 × g
for 45 min at 4°C. The obtained supernatants
were subjected to 0.12% polyethylene-imine
precipitation. SHSPs were first fractionated on a
DEAE–Sepharose column, using a gradient from
0 to 1 M NaCl in 25 mM bis-Tris pH 6.35, 2
mM EDTA, and after desalting further
fractionated on a Source 15Q HR 16/10 column
using the same salt gradient. This yielded
fractions containing both HSPB2 and HSPB3,
and HSPB2 alone. Recombinant HSP27, HSP20
and αB-crystallin were purified in a similar
manner, using pET3a-human-HSP27, pET8c-ratHSP20 and pET3b-human-αB-crystallin as
described previously (33).
SEC-MALLS
SEC-MALLS analyses were performed
by chromatographic separation of samples (100
µg), on an Agilent 1200 system, using a TSKGel3000SW column (TOSOH-BIOSEP) at a
flow rate of 0.5 mL/min in 10 mM sodium
citrate, pH 6.25, 100 mM NaCl. MALLS
analysis of a sample was performed
continuously on the column eluate, as it passed
through a triple-angle miniDAWN™ TREOS
light scattering detector in series with an Optilab
rEX refractive index instrument (both from
Wyatt Technologies, Inc). Data were analyzed
using Astra v5.3.2, a dn/dc value of 0.185, an A2
value of 0, and a 1st order Zimm fit.
Far-UV circular dichroism spectroscopy
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fluorescence emission was measured at 490 nm
using an excitation wavelength of 390 nm.
Chaperone assays
To
measure
the
chaperone-like
properties of sHSPs the insulin protection assay
described by Farahbakhsh et al. (37) and the
citrate synthase (CS) assay described by Kappé
et al. (38) were used. Briefly, for the insulin
protection assay the proteins were dialyzed
overnight at 4 °C against buffer containing 20
mM sodium phosphate, pH 6.9, and 20 mM
Na2SO4. In a final volume of 1 mL, 250 µg

manually, the inner cell housing scribe line on
the bottom of the cell was visually aligned with
the inner rotor hole scribe lines. Once the
vacuum was less than 5 µm, the rotor was
allowed to reach the set temperature of 22 °C
and then was equilibrated for 1 hour before
accelerating the rotor to the maximum speed of
42,000 rpm. The cells were scanned at 276 nm
as frequently as possible, using a radial
increment of 0.003 cm. At the end of the
experiment, the data were analyzed by Sedfit
(35).
The c(s) continuous distribution model
was used with input parameters that include
radial position for the cell bottom and initial
position for the meniscus, an initial estimate of
frictional coefficient ratio (f/f0) of 1.2, the radial
data range and sedimentation coefficient range
(0.5-20 S, the resolution was set at 200) for
fitting. The solvent density and viscosity as well
as the partial specific volume were calculated
using the public domain software program
Sednterp (36). The calculated partial specific
volume of the HSPB2/B3 oligomer was
corrected for the subunit ratio of 3:1. An initial
c(s) distribution was generated using these
parameters. Subsequently, it was optimized
using the meniscus position and f/f0 as floating
parameters. Using the integration tool provided
in Sedfit, the relative concentration and weight
average sedimentation coefficients were
determined for each species. In all cases
regularization with Tikhonov-Phillips obtained
the best results. The root mean square deviation
(rmsd) for all analysis was < 0.004.
ANS binding
To study the binding of the hydrophobic
probe 1-anilino-8-naphthalenesulfonic acid

HSPB2/B3 or αB-crystallin was incubated with
250 µg bovine insulin (Sigma) at 40 °C for 5
minutes. The denaturation of insulin was
initiated by adding 3 mg dithiothreitol (DTT),
and absorbance was measured at 360 nm for 15
minutes at 40 °C in a Perkin Elmer Lambda 2
UV/VIS spectrophotometer. For the CS
protection assay the proteins were dialyzed
overnight at 4 °C against 40 mM Hepes-KOH,
pH 7.5. 70 µg sHSP was incubated at 44 °C for 5
minutes. After adding 70 mg CS to a total
volume of 1 mL the heat induced denaturation of
the substrate was followed at 44 °C by
measuring the turbidity at 360 nm for 45 minutes
in a Perkin Elmer Lambda 2 UV/VIS
spectrophotometer.
Colony Survival Assay
Cells transformed with the appropriate
bacterial expression construct were first grown
overnight. All cell suspensions were then diluted
to OD580 = 0.6, and protein expression was
induced for 1 hour by adding 350 µM isopropylβ-D-thiogalactopyranoside. After induction cells
were heat-shocked at 48 °C for 60 minutes, after
which the cell cultures were diluted to OD580 =
0.06. The recovery was monitored during 4.5
hour at 37 °C by measuring the increase of
OD580 at 30 minute time intervals.
Co-immunoprecipitation assay

(ANS), 10 µM HSPB2/B3 in 10 mM sodium
phosphate buffer (pH 7.4) containing 100 mM
NaCl and 500 mM ANS in methanolic solution
was used to make a series of mixtures with
different molar ratio’s. The mixtures were
incubated for 10 min at 37 °C after which the

Purified HSPB2/B3 (1 µg) and HSPB2
(0.5 µg) were incubated either alone (negative
control) or together with HSP20, HSP27, αB4

crystallin (5 µg) or a mixture of the three

concentration of 15 mg/mL (0.77 mM). This
solution was subsequently diluted into 1 mg/mL
final concentration and analyzed by size
exclusion chromatography coupled with multiangle laser light scattering (SEC-MALLS). In
the obtained chromatogram HSPB2/B3 appeared
in three peaks; a major peak A and a smaller
peak B, which is poorly separated from a third
peak C (Fig. 1B). Based on the MALLS
measurements, the molecular masses of the
HSPB2/B3 complexes in peaks A and B are 78
and 166 kDa, respectively. Peak C contains
several high molecular weight complexes with
masses ranging from 250 to 300 kDa.

proteins (each 5 µg) in TEN buffer (25 mM Tris
pH 8.0, 100 mM NaCl, 2 mM EDTA and 0.05%
NP40) for 60 minutes at room temperature. After
the incubation, antibodies directed against
HSPB2, HSP20, αB-crystallin (all three raised in
rabbits) or HSP27 (Stressgen) coupled to protein
A beads (Roche) were added to the indicated
mixtures and rotated for 60 minutes. The beads
were then pelleted and washed 3 times with 1
mL TEN buffer. The proteins bound to the beads
were separated by SDS-PAGE and analyzed by
Western blotting.
RESULTS
HSPB2
together
with
HSPB3
forms
heterooligomeric complexes
Initially, it was attempted to express and
purify HSPB2 and HSPB3 separately in order to
study their properties and to characterize the
HSPB2/B3
complex.
Although
separate
expression of both proteins was adequate,
purification and stability turned out to be
unsatisfactory under a variety of conditions. Coexpression of HSPB2 with HSPB3 already
allowed the formation of the complex in E. coli,
and from the extract of those cells HSPB2/B3
could successfully be purified by ion exchange
chromatography. In the initial DEAE step,
HSPB2 eluted at low salt concentrations together
with HSPB3 in a certain ratio. At higher salt
concentrations, HSPB2 eluted mainly without
HSPB3 (Fig. 1A), indicating that E. coli
expressed an excess of HSPB2 compared to
HSPB3. Unfortunately, HSPB2 was only stable
in a diluted form and started to precipitate as
soon as the concentration was increased. Due to
this behavior the biochemical properties of
HSPB2 on its own could not be analyzed.
Fractions containing both HSPB2 and HSPB3
were pooled and further purified on a Source Q
column. The obtained HSPB2 and HSPB3 were
concentrated in 20 mM phosphate buffer pH 7.5
with 100 mM NaCl and 2 mM EDTA to a

HSPB2/B3 forms hetero-oligomeric complexes
with a fixed subunit ratio
To further characterize the HSPB2/B3
oligomers, the complexes were analyzed by
nano-ESI-MS under conditions that preserve
non-covalent
interactions
(39).
The
unprecedented accuracy of this technique can be
used to calculate the exact subunit stoichiometry
of the hetero-oligomers. Prior to mass
spectrometry, the proteins were separated on a
Superose 6 column, using a 200 mM ammonium
acetate buffer at pH 6.8, which gave a similar
elution pattern with two relatively sharp peaks A
and B, and a broader peak C (Fig. 2A). This
broadness is likely caused by the mass variations
of the large complexes shown by the MALLS
measurements (Fig. 1B). Mass spectra were
collected for oligomeric HSPB2/B3 present in
peak A and peak B containing a fraction of peak
C. Analysis of peak A (Fig. 2B) revealed an
intense series of peaks (T) between m/z 3,5005,250, which were found to arise from an
HSPB2/B3 complex with a mass of 77,887 ± 34
Da. According to the mass this is a tetrameric
complex (T, 4-mer) composed of three HSPB2
subunits (calculated mass 20,235 Da) and one
HSPB3 subunit (calculated mass 16,968 Da). A
low intensity charge state series between m/z
1,500-3,200 could be observed (insert to panel
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relative amount of each oligomer (Table 1). The
heterotetramer (4-mer) forms more than 60% of
the amount of all species, indicating that this
oligomer is the predominant form.

B), which arise from three different species:
HSPB3 monomer with a mass of 17,024 ±1 Da,
a heterodimer (heteroD) with a mass of 37,294 ±
9 Da (calculated mass 37,203 Da), and a HSPB2
homodimer (homoD) with a mass of 40,458 ±39
Da (calculated mass 40,470 Da). The
predominant charge state series found in peak B
(Fig. 2C) corresponds with the mass of an
octamer (O, 8-mer) being 155,696 ±53 Da
composed of six HSPB2 and two HSPB3
subunits. The next most intense peak series in
this spectrum (mass 467,588 ±127 Da)
corresponds to a 24-mer and has the same 3:1
subunit ratio observed in case of the tetra- and
octa-meric complexes. A low intensity charge
state series between m/z 5800-8000 (insert to
panel C) was found to arise from a dodecamer
oligomer (DoD, 12-mer) with a mass of 233,767
± 94 and another low intensity series arises from
a hexadecamer (hexD, 16 mer) with a mass of
311,853 ±19 Da. Both the dodecamer and
hexadecamer conform to the same subunit ratio
observed for the tetramer, octamer and 24-mer.
In order to determine the relative
amount of each oligomeric complex, a
sedimentation velocity centrifugation analysis,
using an analytical ultracentrifuge (Experimental
Procedures) was performed. By employing the
c(s) continuous distribution model, 7 different
complexes varying in sedimentation rate
between 4.6 and 19.4 S were identified (Fig. 3).
Based on the calculated molecular masses of
these complexes (Table 1), 5 of these complexes
have been identified by nano-ESI-MS as being
4-, 8-, 12-, 16- and 24-mer. Also a complex with
the mass of a 20-mer could be detected, which
was not observed by nano-ESI-MS, likely
because of its low abundance. Beside these
complexes, also a large complex with a mass of
638,000 Da was detected by analytical
ultracentrifugation, but the accuracy of this mass
was not sufficient to determine if this complex
belongs to the series of well-defined oligomers.
By analyzing the peak areas we determined the

Heat-induced structural changes of HSPB2/B3
The chaperone-like activity of sHSPs is
likely modulated by structural changes in
response to stress, such as elevated temperatures
(40). To assess heat-induced structural changes
of HSPB2/B3 a series of far-UV circular
dichroism (CD) spectra were recorded at
temperatures ranging from 20 till 80 degrees.
The CD spectra for HSPB2/B3 recorded
between 20 and 40 °C were quite similar and
showed a relatively broad minimum around 215
nm (Fig. 4A). Above 40 °C, a change in the
spectra was observed, and found to be most
pronounced at 204 nm. At this wavelength the
negative ellipticity is characteristic for random
coil structures caused by the unfolding of the
subunits (41). This negative ellipticity at 204 nm
slightly increased at temperatures ranging from
40 to 50 °C and strongly increased between 50
and 64 degrees, with an inflection point of the
unfolding curve at 56 degrees (Fig. 4B).
Surface hydrophobicity of HSPB2/B3
The
surface
hydrophobicity
of
HSPB2/B3 was compared with that of αBcrystallin. αB-crystallin has a strong affinity for
unfolding proteins, which correlates well to the
surface hydrophobicity of this sHSP (42). The
surface hydrophobicity was measured with the
hydrophobic probe ANS, a fluorescence dye
with increasing fluorescence intensity upon
binding to exposed hydrophobic surfaces. The
fluorescence intensity was measured at different
ANS to protein molar ratios (Fig. 5).
Remarkably, for HSPB2/B3 very little
fluorescent ANS signal was recorded, even at
high molar ratios, showing that, compared to
αB-crystallin, HSPB2/B3 exhibits very low
ANS binding capacity. This indicates that the
6

surface of HSPB2/B3
hydrophobic.

is

relatively

nonInteraction of HSPB2/B3 with other sHSPs
Although the HSPB2/B3 association in
muscle cell extracts has been suggested to act
mainly as an independent sHSP complex since it

HSPB2/B3 has poor chaperone-like and
thermoprotective activity
A low surface hydrophobicity is an
indication for a poor chaperone-like activity. To
study the chaperone-like activity of HSPB2/B3
three different chaperone assays were used (Fig.
6). In the first assay the ability to prevent
aggregation of dithiothreitol-denatured insulin
was measured. In line with previous data (37),

does not associate with HSP27 and αBcrystallin, a weak interaction between HSP20
and HSPB2 has been detected (23). To analyze
whether the recombinant HSPB2/B3 oligomeric
complexes exhibit similar associating properties,
a mixture containing equal amounts of purified
HSP20, HSP27 and αB-crystallin was allowed to
exchange subunits with HSPB2/B3. In this
experiment purified HSPB2 was used, which in
the diluted form remained soluble during coimmunoprecipitation. After 60 min of incubation
at
room
temperature
HSPB2
was
immunoprecipitated with HSPB2 antiserum
followed by Western blot analysis to detect the
interacting proteins (Fig. 7A). As expected,
HSPB3 was efficiently co-precipitated with
HSPB2 (Fig. 7A lanes 4 and 6). Interestingly,
HSP20 did not co-precipitate with HSPB2/B3,
but was efficiently pulled down with HSPB2,

recombinant αB-crystallin fully inhibited the
DTT-induced aggregation of insulin at a 1-to-1
mass ratio (Fig. 6A). Conversely, practically no
prevention of insulin aggregation was observed
in the presence of HSPB2/B3. In the second
assay the ability to prevent the heat-induced
aggregation of citrate synthase (CS) was
assessed (38). At a 1-to-1 mass ratio both
HSPB2/B3 and αB-crystallin were able to
prevent CS aggregation, although HSPB2/B3
showed significantly less chaperone-like activity
than αB-crystallin (Fig. 6B). In the third assay,

while αB-crystallin and HSP27 co-precipitated
neither with HSPB2/B3 nor HSPB2 (compare
lanes 5 and 6).
In the reciprocal pull-down experiment
specific antibodies directed to HSP20, HSP27

the ability of HSPB2/B3 to confer
thermotolerance to E. coli cells was established
(Fig. 6C). E. coli cells expressing HSPB2/B3,
αB-crystallin or the chaperone-like activity
lacking negative control βB2-crystallin (43),
were heat shocked for 60 minutes at 48 °C, a
temperature at which marginal unfolding of
HSPB2/B3 was detected (Fig. 4B). After heat
shock, cells were diluted in fresh medium and
cell recovery at 37 °C was monitored for 4.5
hours, by measuring the cell density (OD580) at
30 minutes intervals. After 4.5 hours, a

and αB-crystallin were used for the
immoprecipitation and co-precipitated HSPB2
was detected by Western blot analysis (Fig. 7B).
The three sHSPs were incubated with
HSPB2/B3 or HSPB2 either individually (Fig.
7B lanes 3-4) or as a mixture (Fig. 7B lanes 5-6).
Again, only HSP20 showed a clear interaction
with HSPB2, but not with HSPB2/B3. No
quantitative differences of co-precipitated
HSPB2 were observed in the presence of HSP27

considerable growth recovery of αB-crystallin
expressing cells was observed, while cells
expressing HSPB2/B3 or the control protein
were still not recovered. These results show that
HSPB2/B3 has no (Figs 6A and C) or only little
(Fig. 6B) chaperone-like and thermoprotective

and αB-crystallin, indicating that the interaction
between HSP20 and HSPB2 is not affected by
these two sHSPs. These results show that the
HSPB2/B3 complex does not interact with

activity as compared to αB-crystallin.
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HSP20, HSP27 or αB-crystallin, while HSPB2
can indeed form a complex with HSP20.

data showing that HSPB2 interacts with both
itself and HSPB3, while HSPB3 can only
interact with HSPB2 and not itself (23).
Based on the SEC analysis in this study,
in agreement with earlier reports (23;25;45), the
main HSPB2/B3 complex was estimated to be in
the range of an octamer, 150 kDa (Fig. 2A, peak
A). However, this is twice as large as found by
mass spectrometry, MALLS and sedimentation
velocity centrifugation analysis (Fig. 1 and 2B).
This indicates that HSPB2/B3 elutes faster from
a size exclusion column than expected. A
possible explanation for this aberrant behavior
could be the presence of extra space inside the
complex, as has been observed for HSP26 (46).
By heat-induced denaturation we found
that HSPB2/B3 forms a relatively stable
structure, which only at temperature around 56
°C forms extensive random coil structures.
However, the unfolding starts already at 40 °C,
which suggests that at this temperature structural
changes already occur. Such structural changes,
close to physiological temperatures have been
also described for other sHSPs, and thus might
be an important mechanism to regulate the
chaperone-like activity (40).

DISCUSSION
We succeeded to co-express HSPB2 and
HSPB3 as reported in this study, and purified the
oligomeric complex of HSPB2/B3. Interestingly,
HSPB3 was only detected as a component of this
complex, while HSPB2 could also be isolated as
a separate homomeric assembly, albeit in a
poorly soluble form. Analysis of the
recombinant HSPB2/B3 complex by advanced
methods such as SEC-MALLS, Nano-ESI-MS
and sedimentation velocity centrifugation
revealed the presence of a series of heteromeric
oligomers. The masses of these oligomers varied
from 77,897 up to 467,588 Da, corresponding to
assemblies containing 1 to 6 tetramers, each
comprising three HSPB2 and one HSPB3
subunits (Table 1). The tetramer is the most
abundant oligomeric species that can be formed
by HSPB2 and HSPB3. Based on the mass
differences between the higher oligomers, this
structure is the building block for the large
HSPB2/B3 complexes. The 24-mer is likely a
more stable structure compared to the other
higher oligomers, since this complex is relatively
more pronounced as determined by both nanoESI-MS (Fig. 2C) and sedimentation analysis
(compare ratio amount n+4- and n-mer in Table
1). The organization of HSPB2/B3 in distinct
oligomeric structures is a very conspicuous
feature, which to our knowledge, is a feature that
has never been observed for other sHSPs.
By Nano-ESI-MS, small amounts of
HSPB2
homodimers
and
HSPB2/B3
heterodimers have been detected (Fig. 2A). This
observation allowed to draw the conclusion that
the tetramer is composed of dimeric units. Such
dimeric “building blocks” have been suggested
as being a common feature of sHSPs (1;44). In
this case, the tetramer is formed by the
association of one homodimer and one
heterodimer. This fits with the yeast two hybrid

Previously, it was shown that the αcrystallin domain is needed to form the dimer
structures, while the N-terminal and C-terminal
tails are mainly involved in stabilizing the
quaternary structure (44). The C-terminal
extensions can form critical bridges between
neighboring subunits via a conserved IXI/V
sequence (12). The C-terminal extension of
HSPB2 does not contain this conserved
sequence but, based on its length, it could still be
involved in stabilizing the quaternary structure.
However, HSPB3 has an extension of about 5
residues long, which is likely too short to form a
bridge between adjacent α-crystallin domain
dimers. The absence of a long C-terminal
extension in HSPB3 might be an important
factor for the unique nature of the HSPB2/B3
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HSPB2/B3 hardly binds ANS (Fig. 5),
indicating that the surface of the complex is not
very
hydrophobic.
The
low
surface
hydrophobicity is likely to affect the binding of
unfolding proteins (50), and this way, it can
contribute to the observed poor chaperone-like
activity
of
the
HSPB2/B3
complex.
Interestingly, purified homomeric HSPB2 has
been shown to have chaperone-like activity that
protects the kinase DMPK from heat-induced
inactivation (25). By using a diluted preparation
of purified HSPB2, we could also detect a
moderate chaperone-like activity of HSPB2 for
insulin (data not shown). It is thus possible that
HSPB3, at least in part, is responsible for the
low chaperone-like activity of the HSPB2/B3
complex. Therefore, HSPB2/B3 may function as
an inactive storage complex from which HSPB2
has to dissociate in order to become active.
However, the relation between in vitro and in
vivo chaperone-like activity does not always
correlate (51) and thus care must be taken to
extrapolate the in vitro data. It remains possible
that HSPB2/B3 function as a chaperone complex
in vivo only dedicated to specific substrates.
In summary, the results indicate that
HSPB2/B3 forms a series of heterooligomers
with a well-defined subunit ratio and differ in
number of tetramers. They have poor
chaperoning activity and do not interact with
other sHSPs, which is atypical compared to
other sHSPs. Further studies are needed to
understand the structural and cellular functions
of this complex.

complex to form tetramers that can subsequently
assemble into multiple oligomers.
sHSPs expressed in the same cell often
form heteromeric complexes consisting of
several sHSPs, such as those described for αBcrystallin and HSP27 (47). There are also
examples in which more than one type of sHSP
oligomeric complexes can actually exist in the
cytoplasm of a single cell. In higher plants, class
I and II sHSPs are such proteins that can be
found in separate oligomers (48). HSPB2 and
HSPB3 also form separate oligomers, despite
their co-expression with e.g. HSP27, HSP20 and
αB-crystallin in muscle cells. Interestingly,
HSP20 is able to interact with HSPB2 (23),
which raised the question whether HSP20 can
also interact with HSPB2 as part of the
HSPB2/B3
complex.
By
coimmunoprecipitation experiments we have
shown that the HSPB2/B3 complex does not
interact with HSP20 (Fig. 7). Only HSPB2
alone, thus not in complex with HSPB3, binds
relatively well to HSP20. These data show that
HSPB2/B3 is indeed a separate complex not able
to interact with other sHSPs. This is in good
agreement with the yeast two-hybrid studies
showing that only HSP20 and HSPB3 are able to
interact with HSPB2 (23). Recently, HSPB2 has
been found to also interact with HSPB8 (HSP22)
(49). The concentration of HSPB2 and HSPB3
in rat skeletal muscle extract was found to be
0.30 and 0.09 µg/mg of total protein,
respectively (23). Thus the ratio of expression
between the two proteins is close to 3:1, which
suggest that almost all HSPB2 will be present in
the HSPB2/B3 complex. This may explain why
in muscle tissue extract only a minor fraction of
HSPB2 associates with HSP20 (23).
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FIGURE LEGENDS
Figure 1. Separation of HSPB2/B3. (A) A lysate of E. coli cells co-expressing HSPB2 and HSPB3
was separated on a DEAE column with a NaCl gradient. Peak samples were collected and subjected to
SDS-PAGE and stained with Coomassie Brilliant Blue (CBB). (B) Elution pattern of purified
HSPB2/B3 on a TSK-Gel3000SW column was measured by absorption at 280 nm (left axis) in
combination with continuous MALLS measurements converted to molecular masses in Da (right
axis). HSPB2/B3 eluted as relatively sharp peaks A and B at a mass of 78 kDa and 166 kDa, and a
front peak C, containing multiple complexes with increasing masses.
Figure 2. Nanoelectrospray mass spectra of HSPB2/B3. (A) HSPB2/B3 separated by Superose 6
column in 200 mM ammonium acetate pH 6.8. Fractions of peak A and B were collected. Panel (B)
shows the higher oligomeric species observed by mass spectrometry acquired with a sample of peak
A. The dominant charge state series correspond to a HSPB2/B3 tetramer (T) of mass 77897 ± 34 Da
composed of three 20.2 kDa subunits and a single 17.0 kDa subunit. As an insert of panel B, an
expansion of the 1500 – 3500 m/z region is shown. Here, three additional species can be identified: a
monomer (M) with mass 17024 ± 1 Da; a heterodimer (heteroD), with mass 37294 ± 9 Da, composed
of a single copy of each subunit and a homodimer (homoD), with mass 40458 ± 39 Da, composed of
two 20.2 kDa subunits. Panel (C) shows the higher oligomeric species observed by mass
spectrometry, acquired with sample of peak B. The mass of the predominant charge state series in this
spectrum corresponds to an octamer (O) composed of six 20.2 kDa subunits and two 17.0 kDa in the
same subunit ratio observed for the tetrameric species in panel B. The next most intense peak series
corresponds to that of a 24 mer with the same 3:1 subunit ratio observed previously. The insert in
panel C expands the 5700 – 8000 m/z region of the spectrum. A well defined but low intensity series
for a dodecameric oligomer (DoD) with mass 233767 ± 94 Da was detected as well as a low intensity
series for a hexadecamer (hexD) with mass 311853 ± 19 Da. Both the dodecamer and hexadecamer
conform to the same subunit ratio observed for the tetramer, octamer and 24 mer.
Figure 3. Sedimentation velocity analysis of HSPB2/B3. Purified HSPB2/B3 at 1.5 mg/mL in 20 mM
phosphate buffer pH 7.5 containing 100 mM NaCl and 2 mM EDTA was centrifuged at 42,000 rpm in
an analytical ultracentrifuge at 22 °C. A multi-species analysis of the obtained data was used to
calculate the C(s) distribution of S(w).
Figure 4. Far-UV circular dichroism spectra of HSPB2/B3.
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(A) Far-UV circular dichroism spectra (B) negative ellipticity at 204 nm of HSPB2/B3 taken after
every increment of 2 °C from 20 °C till 80 °C . Dark lines in (A) indicate spectra and dark squares
in (B) indicate negative ellipticity at 204 nm taken after increments of 10 °C. Protein concentration
was 250 µg/mL in 10 mM potassium phosphate buffer pH 7.8.
Figure 5. HSPB2/B3 exhibits has a low affinity for the hydrophobic probe ANS.
The ANS binding capacity of HSPB2/B3 ( ) and of αB-crystallin (●) was determined by titrating 10
µM protein with increasing ANS concentrations (plotted as molar ratio ANS/protein) and measuring
intensities of the fluorescence emission maxima at the excitation wavelength set at 390 nm.
Figure 6. HSPB2/B3 exhibits moderate chaperone-like and thermoprotective activity. (A) Chaperone
activity of 250 µg HSPB2/B3 ( ) or αB-crystallin (●) determined by measuring the ability to prevent
DDT-induced aggregation of 250 µg insulin at 40 °C. Insulin alone is indicated by diamonds (¡). (B)
Chaperone activity of 70 µg HSPB2/B3 ( ) or αB-crystallin (●) determined by measuring the ability
to prevent temperature-induced aggregation of 70 µg CS at 44 °C. CS alone is indicated by diamonds
(¡). (C) Thermoprotective activity of HSPB2/B3 or αB-crystallin determined by measuring the
growth of E. coli cells expressing HSPB2/B3 ( ), αB-crystallin (●) or negative control protein βB2
(¡) after a heat shock at 48 °C for 60 minutes.
Figure 7. HSPB2 but not HSPB2/B3 interacts with HSP20. (A) Purified HSPB2 (0.5 µg) and
HSPB2/B3 (1 µg) were incubated alone (lanes 3-4) or with a mixture of HSP20, HSP27 and αBcrystallin (each 5 µg) (lanes 5-6) for 60 min at room temperature and subsequently
immunoprecipitated (IP) using antibodies directed to HSPB2. As a negative control no proteins were
added (lane 2). The precipitated proteins were analyzed by Western blotting using antibodies directed
to the indicated proteins. Lane 1 shows 5% of the input of HSP20, HSP27 and αB-crystallin. (B)
Purified HSPB2 (0.5 µg) and HSPB2/B3 (1 µg) were incubated with 5 µg HSP20 (upper panel), 5 µg
HSP27 (middle panel) or 5 µg αB-crystallin (lower panel) (lanes 3-4) or with a mixture of the three
proteins (each 5 µg) (lanes 5-6) for 60 min at room temperature and subsequently immunoprecipitated
(IP) using the indicated antibodies. As a negative control HSPB2/B3 was incubated with buffer alone
(lane 2). The precipitated proteins were analyzed by Western blotting with anti-HSPB2 serum. Lane 1
shows 5% of the HSPB2/B3 input.
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Table 1. Molecular masses of the detected HSPB2/B3 oligomers as determined by nano-ESI-MS,
MALLS and sedimentation analysis and compared with the calculated masses.
Multimers
n-mer
Calc. Mw
(Da)
4-mer
77,673
8-mer
155,346
12-mer
233,019
16-mer
310,692
20-mer
388,365
24-mer
466,038

Nano-ESI-MS
Mw
(Da)
77,897 ± 34
155,696 ±53
233,767 ± 94
311,853 ± 19
ND
467,588 ±127

MALLS
Mw
(Da)
78,000
166,000
-

Sw (20,w)
(S)
4.6
6.9
8.8
11.1
13.6
16.0
19.4

ND: Not Detected
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Sedimentation velocity analysis (AUC)
Mw
Relative
Ratio amount
(Da)
amount (%)
n+4- and n-mer
73,400
60.4
135,000
25.4
0,4
197,000
7.9
0,3
277,000
3.1
0,4
376,000
0.9
0,3
481,000
1.3
1,4
638,000
0.6
-
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